A Mediterranean Diet Nutrition Education Program for the Reduction of Cardiovascular Disease Risk in the Southeastern U.S.
HHP
A Pilot, Theory-Based, Nutrition Intervention Promoting a Mediterranean Diet for the Reduction of Cardiovascular Disease Risk Factors in a High-Risk Population of the Southeastern United States: The Healthy Hearts Program (HHP)
1 other identifier
interventional
58
1 country
1
Brief Summary
A 12-week, randomized nutrition intervention for the reduction of cardiovascular disease risk factors in a high-risk population in the southeastern United States. The primary objective of this pilot study was to assess the efficacy of a Mediterranean diet intervention (education + extra-virgin olive oil (EVOO) and mixed nut supplementation) versus that of an American Heart Association (AHA) nutrition intervention (education) on serum blood lipid levels as markers for cardiovascular disease risk. Researchers conducting this trial hypothesize that a greater reduction will be seen in cardiovascular disease risk factors in the Mediterranean diet intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cardiovascular-diseases
Started Jan 2017
Shorter than P25 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 23, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 7, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2017
CompletedFirst Submitted
Initial submission to the registry
September 20, 2018
CompletedFirst Posted
Study publicly available on registry
September 25, 2018
CompletedSeptember 27, 2018
September 1, 2018
8 months
September 20, 2018
September 26, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Systolic Blood Pressure Measurement
Measured in mmHg
Change from at baseline blood pressure to 6-weeks
Systolic Blood Pressure Measurement
Measured in mmHg
Change from at baseline blood pressure to 12-weeks
Secondary Outcomes (20)
Diastolic Blood Pressure Measurement
Change from at baseline weight to 6-weeks
Change in Weight
Change from at baseline weight to 12-weeks
Calculation of Body Mass Index (BMI) (kg/m∧2)
Change from baseline weight to 6-weeks
Calculation of BMI (kg/m∧2)
Change from baseline weight to 12-weeks
Concentration of fasted total cholesterol
Change from baseline weight to 6-weeks
- +15 more secondary outcomes
Study Arms (2)
Mediterranean diet group
EXPERIMENTALParticipants will receive both nutrition education on patterns of a Mediterranean style diet as well as olive oil and mixed nuts.
American Heart Association group
ACTIVE COMPARATORParticipants will receive nutrition education on the dietary recommendations for heart health from the American Heart Association.
Interventions
Participants will receive nutrition education and educational materials from a registered dietitian on patients on the patterns of a Mediterranean style diet. Seven education sessions will be delivered through an online platform. Participants will be asked to complete one education session per week for the first six weeks and the final session at week 9.
Participants in the Mediterranean diet group will receive 3 liters of extra-virgin olive oil and 3 pounds of mixed nuts (1.5 pounds raw almonds and 1.5 pounds raw walnuts) at baseline and at 6 weeks. Participants will be educated by oral and written means, on consumption goals of the nuts and olive oil.
Participants will receive nutrition education and educational materials from a registered dietitian on patients on the dietary recommendations from the American Heart Association for heart health. Seven education sessions will be delivered through an online platform. Participants will be asked to complete one education session per week for the first six weeks and the final session at week 9.
Eligibility Criteria
You may qualify if:
- Enrolled in Auburn University's health insurance program during the course of the study or a dependent of the enrollee during the course of the study
- BMI \>24.9 (kg/m2)
- AND Meets two or more of the following
- Screening values classified in the "yellow" or "red" zone for:
- Systolic blood pressure (mmHg): Yellow zone: ≥140, Red zone: ≥160;
- Diastolic Blood pressure (mmHg): Yellow zone: ≥90, Red zone: ≥ 100;
- Fasting blood glucose (mm/dL): Yellow zone: ≥100, Red zone: ≥ 126
- Blood glucose (random) (mg/dL): Yellow zone: 140-200, Red zone \> 200
- Total Cholesterol (mg/dL): Yellow zone: ≥200, red zone: ≥250
- Have a pre-existing diagnosis of hypertension, pre-diabetes, or hypercholesterolemia
- Current smoker (≥1 cigarette/day)
- Are: male (age: 55-80) or female (age: 60-80)
- A family history of premature coronary heart disease
- High risk ethnicity: Black, African American, American Indians/Alaska Natives, Non-Hispanic blacks, Mexican-Americans, Asian, Hispanic/Latino
You may not qualify if:
- Minors that are less than 19 years of age
- Individuals who are not enrolled in the Auburn University health insurance program for the 2016 plan year at baseline and have not yet completed initial visit
- Individuals who have not completed their 2015 "Healthy Tigers" biometric screening between January 1st and December 31st, 2015 (these can be completed by the "Healthy Tigers" staff or by submitting a healthcare provider form from the individuals' physician to the "Healthy Tigers" office), unless enrolled in "TigerMeds".
- Individuals who are pregnant or who intend to become pregnant during the 12-week health and wellness challenge.
- Individuals who anticipate absence or travel throughout the study that would interfere with their ability to complete the analysis at the mid-point and end of challenge.
- Patients with a peanut, tree nut, or olive oil food allergy or intolerance.
- Patients who are unable or unwilling to travel to Auburn University main campus for live health and wellness challenge events, individual assessments, personal appointments, and pre- and post- data collection
- Individuals who have NOT been stabilized on medication to treat or manage high blood pressure, high cholesterol, dyslipidemia, or pre diabetes for at least 12 weeks prior to the study.
- Patients who do not have access to the internet and therefore unable to complete the education portion of the study
- Individuals who have a pacemaker
- Patients who decline participation during informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Auburn University Pharmaceutical Care Center
Auburn, Alabama, 36849, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Michael W Greene, PhD
Auburn University
- PRINCIPAL INVESTIGATOR
Amy W Willis, MS, RD
Auburn University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Auburn University Metabolic Phenotyping Laboratory
Study Record Dates
First Submitted
September 20, 2018
First Posted
September 25, 2018
Study Start
January 23, 2017
Primary Completion
September 7, 2017
Study Completion
September 7, 2017
Last Updated
September 27, 2018
Record last verified: 2018-09
Data Sharing
- IPD Sharing
- Will not share